DVL3 and prostate carcinoma: ASPM binds to disheveled segment polarity protein 3 (DVL-3), a key upstream regulator of canonical Wnt signaling, and prevents it from being degraded by the proteasome, thereby strengthening protein stability and enhancing Wnt-induced β-catenin transcriptional activity in prostate cancer cells (39).